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The possibility that low concentrations of serum bilirubin may be associated with increased risk of ischemic heart disease has been examined in a prospective study of 7685 middle-aged British men. During 11.5 years there were 737 major ischemic heart disease (IHD) events. A U-shaped relationship was observed between serum bilirubin and risk of IHD. Low bilirubin was associated with several cardiovascular risk factors, in particular smoking, low concentrations of high-density lipoprotein cholesterol, low forced expiratory volume in 1 s, and low serum albumin.
The U-shaped relationship persisted even after adjusting for several risk factors. Compared with men in the lowest fifth of the distribution (bilirubin <7 mol/L), those in the middle range (8-9 moVL) showed a 30% reduction in relative risk ERR = 0.68 (95% confidence intervals 0.51-0.89)] in IHD, whereas men in the top fifth (>12 mol/L)
showed similar risk to the lowest fifth [AR = 0.99 (95% confidence intervals 0.73-1.34)1, which persisted after exclusion of men with bilirubin >17 mol/L.
The significance of this U-shaped relationship is unclear, but it could be interpreted as support for the role of endogenous antioxidants in the etiology of IHD.
Indexing Terms: anfioxidants/cho!esterol/risk factors
The major risk factors for ischemic heart disease (IHD) are well documented and include smoking, blood cholesterol, and hypertension (1 ) 4 There is substantial variation in IHD risk between countries (2), within populations (3) , and between socioeconomic groups (4). Major IHD risk factors do not predict subsequent myocardial infarction accurately (5) and do not fully explain declining secular trends in IHD (6) or social class differences (7) . The search for risk factors for IHD that might explain these variations has been stimulated by evidence that free radicals are involved in the pathogenesis of atheroma (8) and that antioxidants, both dietary and endogenous, may be important protective factors (9) .
The antioxidant properties of bilirubin have been recognized for many years (10) (11) (12) The British Regional Heart Study (BRHS).
Subjects and Methods
The BRHS is a prospective study of cardiovascular disease involving 7735 men, ages 40-59 years, selected from the age-sex registers of one group general practice in each of 24 A previous report from the BRHS has shown marked diurnal variation in bilirubin concentrations (20) . There was little difference in mean values up to 1600, but after this, the concentrations decreased steadily and significantly through the afternoon, being 9.1 and 7.2 mmol/L in men screened before and after 1600, respectively.
This difference was not caused by the differences in various other risk factors such as smoking in men screened before and after 1600. The explanation for this decrease is uncertain, but may be the result of food intake (20) , fasting having been shown to increase bilirubin concentration
(21).
Because of the concern regarding the marked diurnal variation and the uncertainty of the nature of the decrease in bilirubin after 1600, we analyzed the data separately for the men screened before and after 1600. The major analyses reported here involved the two-thirds of men screened before 1600, with reference made to the findings in the other third screened after 1600.
Preexisting Disease
The men were asked to recall a doctors diagnosis of angina, myocardial infarction, diabetes, and several other disorders listed on the questionnaire.
The WHO (Rose) chest pain questionnaire was administered to all men at the initial examination (22) , and a three-orthogonal lead electrocardiogram was recorded with the subject recumbent and having been at rest at least 30 mm before the recording.
Men with evidence of IHD were defined as those with a diagnosis of angina or heart attack made by a doctor, a response on WHO (Rose) questionnaire In all, 1914 men (25%) had preexisting evidence of IHI).
Follow-up
All men were followed up for all-cause mortality and for cardiovascular morbidity for 11.5 years (23 
Results
In the 7685 men with complete data on biirubin and time of examination, the mean (geometric) concentration of bilirubin was 8.3 (range 1-86 .tmol/L). During the follow-up period of 11.5 years, 737 major IHD events (fatal and nonfatal) occurred in the 7685 men. To assess the relationship between biirubin and risk of major IHD, we divided the entire cohort of men by absolute concentrations in an attempt to approximate fifths of the overall distribution.
The relationship was examined separately in men screened before and after 1600. The IHD event rate/1000 person-years was similar in both groups (8.9 vs 9.0/1000 person years). (1, lowest; 5, highest time of screening. A U-shaped relationship was observed between bilirubin and risk of major IHD events, which was most marked in the men screened before 1600. The U-shaped pattern seen in the men screened after 1600 was similar but less consistent.
Bilirubin and Coronary Risk Factors
The relationship between bilirubin and factors previously shown to be associated with major coronary heart disease events or mortality was examined. Table 1 
Adjustment for Confounding Factors
To assess the effects of confounding factors and because the biological factors may serve as mediating factors, we adjusted first for preexisting disease and life style factors, i.e., age, smoking, physical activity, social class, alcohol intake, body mass index, preexisting IHD, history of diabetes, and use of antihypertensive treatment (Table 3) . Adjustment for these factors made little difference to the U-shaped relationship seen. Further adjustment for the biological factors, i.e., systolic blood pressure, cholesterol, HDL-cholesterol, FEV1, blood glucose, and serum albumin, increased the risk in the top fifth ( Table 3) . As compared with men in the third group, men in the top and bottom fifths of the distribution both showed significantly higher risk (P = 0.007 and P = 0.006, respectively).
A test for the U-shaped relationship fitting a linear and quadratic effect of bilirubin showed a significant indication of a U-shaped relationship (quadratic term; P = 0.005). In men screened after 1600, a similar but less consistent U-shaped curve was seen. The relative risks (and 95% confidence intervals) for the five groups were 1.0, 1.2 (0.8-1.6), 0.9 (0.7-1.3), 0.7 (0.4-1.2), and 1.2 (0.8-1.8), but a formal test for the U-shaped relationship fitting a quadratic term was not statistically significant.
Current Smoking and Preexisting IHD
Because of the strong association between smoking and bilirubin, we also examined the relationship separately in current and noncurrent cigarette smokers. Analysis was confined to the men screened before 1600. A U-shaped relationship was seen in both groups. The U-shaped relationship was seen in men both with and without preexisting IHD (data not shown).
High Bilirubin and Gilbert Syndrome
Gilbert syndrome is characterized by hyperbilirubinemia in the absence of functional liver disease. To assess whether the increased risk of IHD seen in the top fifth of the bilirubin distribution compared with 
